An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors

by palligoelme@gmail.com | Dec 29, 2025 | Clinical Trials

​ Conditions: Advanced Malignant Solid Tumor Interventions: Drug: RPTR-1-201; Drug: PD-1 / PD-L1 monoclonal antibody Sponsors: Repertoire Immune Medicines Not yet recruiting Conditions: Advanced Malignant Solid Tumor Interventions: Drug: RPTR-1-201; Drug: PD-1 / PD-L1...

The Validity and Reliability of the Modified O’Sullivan Functional Balance (mOFB) Test for Multiple Sclerosis

by palligoelme@gmail.com | Dec 29, 2025 | Clinical Trials

​ Conditions: MULTİPLE SCLEROSİS; BALANCE; VALİDİTY; RELİABİLİTY Sponsors: Sanko University Completed Conditions: MULTİPLE SCLEROSİS; BALANCE; VALİDİTY; RELİABİLİTY Sponsors: Sanko University Completed 

A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants

by palligoelme@gmail.com | Dec 29, 2025 | Clinical Trials

​ Conditions: Healthy Volunteers Interventions: Drug: E2086 Sponsors: Eisai Inc. Not yet recruiting Conditions: Healthy Volunteers Interventions: Drug: E2086 Sponsors: Eisai Inc. Not yet recruiting 

Regional Anesthesia in Ambulatory Endovenous Ablation Surgery

by palligoelme@gmail.com | Dec 29, 2025 | Clinical Trials

​ Conditions: Discharge Time; Spinal Anesthesia; Ambulatory Surgery; Femoral Nerve Block Interventions: Procedure: Femoral nerve block; Procedure: Spinal anesthesia Sponsors: Ankara Etlik City Hospital Recruiting Conditions: Discharge Time; Spinal Anesthesia;...

SHR-A1811 Plus Pertuzumab as Neoadjuvant Therapy for Early or Locally Advanced HR-Positive HER2-Positive Breast Cancer: A Prospective, Open-Label, Phase II Study

by palligoelme@gmail.com | Dec 29, 2025 | Clinical Trials

​ Conditions: SHR-A1811; HER2-Postive Breast Cancer; HR+ Breast Cancer; Early Breast Cancer; Locally Advanced Breast Cancer Interventions: Drug: SHR- A1811 Sponsors: Tianjin Medical University Cancer Institute and Hospital Not yet recruiting Conditions: SHR-A1811;...